ESSA Pharma (EPIX) News Today $1.91 0.00 (0.00%) Closing price 08/19/2025 04:00 PM EasternExtended Trading$1.92 +0.01 (+0.26%) As of 08/19/2025 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EPIX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Aldebaran Capital LLC Has $899,000 Holdings in ESSA Pharma Inc. (NASDAQ:EPIX)August 18 at 7:36 AM | marketbeat.comESSA Pharma (NASDAQ:EPIX) Posts Quarterly Earnings Results, Beats Estimates By $0.08 EPSAugust 16, 2025 | marketbeat.comESSA Pharma Announces $80M Capital DistributionAugust 14, 2025 | msn.comEssa Pharma Inc. Announces Ex-Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash DistributionAugust 14, 2025 | prnewswire.comESSA Pharma Inc. (NASDAQ:EPIX) Shares Sold by Altium Capital Management LLCAugust 14, 2025 | marketbeat.comEssa Pharma Inc. Announces US$80 Million Cash Distribution to ShareholdersAugust 6, 2025 | prnewswire.comESSA Pharma Announces Tax Implications of Cash DistributionAugust 1, 2025 | msn.comESSA Pharma (EPIX) Expected to Announce Quarterly Earnings on MondayJuly 28, 2025 | marketbeat.comESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to ShareholdersJuly 23, 2025 | prnewswire.comESSA Pharma (NASDAQ:EPIX) Trading Up 8.8% - What's Next?July 14, 2025 | marketbeat.com$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ESSA Pharma Inc. (NASDAQ: EPIX)July 14, 2025 | globenewswire.comEPIX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of ESSA Pharma Inc. is Fair to ShareholdersJuly 14, 2025 | businesswire.comESSA Pharma to be Acquired by XenoTherapeuticsJuly 14, 2025 | tipranks.comESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash TransactionJuly 14, 2025 | prnewswire.comEPIX | Essa Pharma Inc. Annual Income Statement - MarketWatchJuly 3, 2025 | marketwatch.comESSA Pharma (NASDAQ:EPIX) Shares Pass Below Fifty Day Moving Average - Should You Sell?June 21, 2025 | marketbeat.com211,204 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Acquired by Two Sigma Investments LPJune 11, 2025 | marketbeat.comBank of America Corp DE Buys 812,302 Shares of ESSA Pharma Inc. (NASDAQ:EPIX)June 5, 2025 | marketbeat.comSoleus Capital Management L.P. Has $4.05 Million Stock Position in ESSA Pharma Inc. (NASDAQ:EPIX)May 21, 2025 | marketbeat.comTang Capital Management LLC Invests $7.70 Million in ESSA Pharma Inc. (NASDAQ:EPIX)May 20, 2025 | marketbeat.comRTW Investments LP Sells 2,148,494 Shares of ESSA Pharma Inc. (NASDAQ:EPIX)May 18, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Sells 229,157 Shares of ESSA Pharma Inc. (NASDAQ:EPIX)May 17, 2025 | marketbeat.comESSA Pharma Inc. Explores Strategic Alternatives After Clinical Trial TerminationMay 9, 2025 | tipranks.comESSA Pharma (EPIX) Projected to Post Earnings on TuesdayMay 8, 2025 | marketbeat.comESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025May 8, 2025 | prnewswire.comMarshall Wace LLP Makes New Investment in ESSA Pharma Inc. (NASDAQ:EPIX)May 7, 2025 | marketbeat.comAltium Capital Management LLC Takes $2.56 Million Position in ESSA Pharma Inc. (NASDAQ:EPIX)April 20, 2025 | marketbeat.comESSA Pharma (NASDAQ:EPIX) Stock Crosses Below 50 Day Moving Average - Should You Sell?April 14, 2025 | marketbeat.com397,523 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Purchased by Aldebaran Capital LLCApril 6, 2025 | marketbeat.comESSA Pharma (NASDAQ:EPIX) Stock Price Passes Below 50 Day Moving Average - Here's WhyMarch 26, 2025 | marketbeat.comESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIXMarch 25, 2025 | prnewswire.comEPIX Deadline Today: Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Large Losses to Contact the Firm for Information About Their RightsMarch 25, 2025 | businesswire.comESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2025 Deadline to file Lead Plaintiff MotionMarch 24, 2025 | globenewswire.comFINAL REMINDER EPIX DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts ESSA Pharma Inc. Investors to Participate in the Class Action Lawsuit!March 24, 2025 | markets.businessinsider.comThe Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIXMarch 24, 2025 | prnewswire.comESSA Pharma Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights – EPIXMarch 24, 2025 | globenewswire.comEPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. ...March 23, 2025 | gurufocus.comEPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. ...March 23, 2025 | gurufocus.comEPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 23, 2025 | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA PharmaMarch 23, 2025 | globenewswire.comEPIX DEADLINE TUESDAY: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 22, 2025 | investing.comEPIX DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 21, 2025 | investing.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit – EPIXMarch 21, 2025 | globenewswire.comFaruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIXMarch 21, 2025 | prnewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIXMarch 21, 2025 | prnewswire.comEPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPMarch 20, 2025 | investing.comEPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIXMarch 20, 2025 | globenewswire.comThe Gross Law Firm Reminds ESSA Pharma Inc. ...March 20, 2025 | gurufocus.comThe Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIXMarch 20, 2025 | globenewswire.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIXMarch 20, 2025 | prnewswire.com Get ESSA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address EPIX Media Mentions By Week EPIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EPIX News Sentiment▼1.020.47▲Average Medical News Sentiment EPIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EPIX Articles This Week▼76▲EPIX Articles Average Week Get ESSA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Arcturus Therapeutics News Corvus Pharmaceuticals News Abeona Therapeutics News Olema Pharmaceuticals News Aldeyra Therapeutics News Amarin News Benitec Biopharma News Rocket Pharmaceuticals News Inhibrx Biosciences News Neurogene News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EPIX) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWinning the AI WarWhat’s really driving the trade wars, reshoring, and sweeping executive orders? According to Porter Stansberry...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access